Biologics and biosimilars: what, why and how?

被引：21
|
作者：
Chan, Juliana C. N. [1 ,2 ,3 ]
Chan, Anthony T. C. [4 ,5 ,6 ]
机构：
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Divis Clin Pharmacol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong Inst Diabet & Obes, Divis Clin Pharmacol, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Prince Wales Hosp, Clin Res Management Off, Shatin, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Prince Wales Hosp, Sir YK Pao Ctr Canc Hong Kong Canc Inst, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[5] Chinese Univ Hong Kong, Prince Wales Hosp, Partner State Key Lab Oncol South China, Shatin, Hong Kong, Peoples R China
[6] Chinese Univ Hong Kong, Prince Wales Hosp, Phase Clin Trial Ctr 1, Shatin, Hong Kong, Peoples R China
来源：
ESMO OPEN | 2017年 / 2卷 / 01期
关键词：
D O I：
10.1136/esmoopen-2017-000180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Biologics or biosimilars: What is the difference?
    Ghosh, Aparajita
    Das, Anupam
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (06): : 683 - U182
  • [2] Author reply: Biologics or biosimilars: What is the difference?
    Sharma, Vinod Kumar
    Bhari, Neetu
    Gupta, Somesh
    Sahni, Kanika
    Khanna, Neena
    Ramam, M.
    Sethuraman, G.
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (06): : 684 - 686
  • [3] Pre-clinical development of biologics - the what, how and why
    Leipold, Douglas
    DRUG METABOLISM REVIEWS, 2016, 48 : 19 - 19
  • [4] Pharmacovigilance of biosimilars - Why is it different from generics and innovator biologics?
    Gupta, Ranjan
    JOURNAL OF POSTGRADUATE MEDICINE, 2020, 66 (02) : 116 - 116
  • [5] Pharmacovigilance of biosimilars - Why is it different from generics and innovator biologics?
    Oza, B.
    Radhakrishna, S.
    Pipalava, P.
    Jose, V.
    JOURNAL OF POSTGRADUATE MEDICINE, 2019, 65 (04) : 227 - 232
  • [6] Biologics and biosimilars
    Patel, Palak K.
    King, Caleb R.
    Feldman, Steven R.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (04) : 299 - 302
  • [7] Biologics and biosimilars
    Gudmundsson, Kolbeinn
    LAEKNABLADID, 2014, 100 (05): : 267 - 267
  • [8] Pharmacovigilance of biologics and biosimilars
    Trifiro, G.
    DRUG SAFETY, 2017, 40 (10) : 1036 - 1036
  • [9] Understanding biologics and biosimilars
    Guerriaud, Mathieu
    Rodriguez, Caroline
    ACTUALITES PHARMACEUTIQUES, 2023, 62 (631): : 22 - 25
  • [10] Biologics and Biosimilars in Psoriasis
    Ahmed, Sk Shahriar
    De, Abhishek
    Das, Sudip
    Manchanda, Yashpal
    INDIAN JOURNAL OF DERMATOLOGY, 2023, 68 (03) : 282 - 295
12345